ArticleACS omega2026
A Superhydrophilic Au-Coated Monolayer Polystyrene Sphere Substrate for Uniform Surface-Enhanced Raman Spectroscopy.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Uniform molecular dispersion and strong signal enhancement are critical for reproducible surface-enhanced Raman spectroscopy (SERS). However, conventional SERS substrates often suffer from poor wettability, leading to nonuniform analyte deposition and signal fluctuation. Herein, we present a superhydrophilic SERS substrate composed of gold-coated monolayer polystyrene spheres (Au-MPS), fabricated via doctor-blade-assisted colloidal lithography, followed by gold sputtering. The resulting Au-MPS exhibits both excellent wettability and tunable plasmonic properties. Optical, morphological, and spectroscopic characterizations reveal distinct plasmonic coupling behavior, with a maximum enhancement factor of ∼10
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.